Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of HER2 ErbB2 Antibodies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of HER2 ErbB2 Antibodiesmarket, defines the market attractiveness level of HER2 ErbB2 Antibodies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of HER2 ErbB2 Antibodies industry, describes the types of HER2 ErbB2 Antibodies market, the applications of major players and the market size, and deeply analyzes the current situation of the global HER2 ErbB2 Antibodies market and the development prospects and opportunities of HER2 ErbB2 Antibodies industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global HER2 ErbB2 Antibodies market in Chapter 13.
By Player:
Proteintech Group, Inc
Abnova Corporation
Thermo Fisher Scientific
Cell Signaling Technology (CST)
Biocon Limited
Novartis AG
Bio-Techne (Novus Biologicals, LLC)
InvivoGen
Atlas Antibodies
By Type:
Trastuzumab
Lapatinib
Ado-trastuzumab Emtansine
Pertuzumab
Everolimus
By End-User:
Hospitals
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 HER2 ErbB2 Antibodies Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 HER2 ErbB2 Antibodies Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 HER2 ErbB2 Antibodies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 HER2 ErbB2 Antibodies Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise HER2 ErbB2 Antibodies Market Analysis and Outlook to 2022
-
7.1 Global HER2 ErbB2 Antibodies Consumption (2017-2022)
-
7.2 United States HER2 ErbB2 Antibodies Consumption (2017-2022)
-
7.3 Europe HER2 ErbB2 Antibodies Consumption (2017-2022)
-
7.4 China HER2 ErbB2 Antibodies Consumption (2017-2022)
-
7.5 Japan HER2 ErbB2 Antibodies Consumption (2017-2022)
-
7.6 India HER2 ErbB2 Antibodies Consumption (2017-2022)
-
7.7 South Korea HER2 ErbB2 Antibodies Consumption (2017-2022)
8 Region and Country-wise HER2 ErbB2 Antibodies Market Analysis and Outlook to 2028
-
8.1 Global HER2 ErbB2 Antibodies Consumption Forecast (2022-2028)
-
8.2 United States HER2 ErbB2 Antibodies Consumption Forecast (2022-2028)
-
8.3 Europe HER2 ErbB2 Antibodies Consumption Forecast (2022-2028)
-
8.4 China HER2 ErbB2 Antibodies Consumption Forecast (2022-2028)
-
8.5 Japan HER2 ErbB2 Antibodies Consumption Forecast (2022-2028)
-
8.6 India HER2 ErbB2 Antibodies Consumption Forecast (2022-2028)
-
8.7 South Korea HER2 ErbB2 Antibodies Consumption Forecast (2022-2028)
9 Global HER2 ErbB2 Antibodies Market Outlook by Types and Applications to 2022
-
9.1 Global HER2 ErbB2 Antibodies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Trastuzumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lapatinib Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Ado-trastuzumab Emtansine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Pertuzumab Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Everolimus Consumption and Growth Rate (2017-2022)
-
9.2 Global HER2 ErbB2 Antibodies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global HER2 ErbB2 Antibodies Market Outlook by Types and Applications to 2028
-
10.1 Global HER2 ErbB2 Antibodies Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Trastuzumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lapatinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Ado-trastuzumab Emtansine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Pertuzumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Everolimus Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global HER2 ErbB2 Antibodies Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global HER2 ErbB2 Antibodies Import and Export Analysis (Top 5 Countries)
-
11.1 Global HER2 ErbB2 Antibodies Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global HER2 ErbB2 Antibodies Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 HER2 ErbB2 Antibodies Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global HER2 ErbB2 Antibodies Market Competitive Analysis
-
14.1 Proteintech Group, Inc
-
14.1.1 Proteintech Group, Inc Company Details
-
14.1.2 Proteintech Group, Inc HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Proteintech Group, Inc HER2 ErbB2 Antibodies Product and Service
-
14.2 Abnova Corporation
-
14.2.1 Abnova Corporation Company Details
-
14.2.2 Abnova Corporation HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Abnova Corporation HER2 ErbB2 Antibodies Product and Service
-
14.3 Thermo Fisher Scientific
-
14.3.1 Thermo Fisher Scientific Company Details
-
14.3.2 Thermo Fisher Scientific HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Thermo Fisher Scientific HER2 ErbB2 Antibodies Product and Service
-
14.4 Cell Signaling Technology (CST)
-
14.4.1 Cell Signaling Technology (CST) Company Details
-
14.4.2 Cell Signaling Technology (CST) HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Cell Signaling Technology (CST) HER2 ErbB2 Antibodies Product and Service
-
14.5 Biocon Limited
-
14.5.1 Biocon Limited Company Details
-
14.5.2 Biocon Limited HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biocon Limited HER2 ErbB2 Antibodies Product and Service
-
14.6 Novartis AG
-
14.6.1 Novartis AG Company Details
-
14.6.2 Novartis AG HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis AG HER2 ErbB2 Antibodies Product and Service
-
14.7 Bio-Techne (Novus Biologicals, LLC)
-
14.7.1 Bio-Techne (Novus Biologicals, LLC) Company Details
-
14.7.2 Bio-Techne (Novus Biologicals, LLC) HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bio-Techne (Novus Biologicals, LLC) HER2 ErbB2 Antibodies Product and Service
-
14.8 InvivoGen
-
14.8.1 InvivoGen Company Details
-
14.8.2 InvivoGen HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 InvivoGen HER2 ErbB2 Antibodies Product and Service
-
14.9 Atlas Antibodies
-
14.9.1 Atlas Antibodies Company Details
-
14.9.2 Atlas Antibodies HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Atlas Antibodies HER2 ErbB2 Antibodies Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of HER2 ErbB2 Antibodies
-
Figure HER2 ErbB2 Antibodies Picture
-
Table Global HER2 ErbB2 Antibodies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HER2 ErbB2 Antibodies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global HER2 ErbB2 Antibodies Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global HER2 ErbB2 Antibodies Consumption by Country (2017-2022)
-
Figure United States HER2 ErbB2 Antibodies Consumption and Growth Rate (2017-2022)
-
Table Europe HER2 ErbB2 Antibodies Consumption and Growth Rate (2017-2022)
-
Figure China HER2 ErbB2 Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Japan HER2 ErbB2 Antibodies Consumption and Growth Rate (2017-2022)
-
Figure India HER2 ErbB2 Antibodies Consumption and Growth Rate (2017-2022)
-
Figure South Korea HER2 ErbB2 Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global HER2 ErbB2 Antibodies Consumption Forecast by Country (2022-2028)
-
Figure United States HER2 ErbB2 Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe HER2 ErbB2 Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure China HER2 ErbB2 Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan HER2 ErbB2 Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India HER2 ErbB2 Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea HER2 ErbB2 Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Trastuzumab Consumption and Growth Rate (2017-2022)
-
Figure Global Lapatinib Consumption and Growth Rate (2017-2022)
-
Figure Global Ado-trastuzumab Emtansine Consumption and Growth Rate (2017-2022)
-
Figure Global Pertuzumab Consumption and Growth Rate (2017-2022)
-
Figure Global Everolimus Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Trastuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lapatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ado-trastuzumab Emtansine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pertuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Everolimus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global HER2 ErbB2 Antibodies Import by Region (Top 5 Countries) (2017-2028)
-
Table Global HER2 ErbB2 Antibodies Export by Region (Top 5 Countries) (2017-2028)
-
Table Proteintech Group, Inc (Foundation Year, Company Profile and etc.)
-
Table Proteintech Group, Inc HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Proteintech Group, Inc HER2 ErbB2 Antibodies Product and Service
-
Table Abnova Corporation (Foundation Year, Company Profile and etc.)
-
Table Abnova Corporation HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abnova Corporation HER2 ErbB2 Antibodies Product and Service
-
Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific HER2 ErbB2 Antibodies Product and Service
-
Table Cell Signaling Technology (CST) (Foundation Year, Company Profile and etc.)
-
Table Cell Signaling Technology (CST) HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cell Signaling Technology (CST) HER2 ErbB2 Antibodies Product and Service
-
Table Biocon Limited (Foundation Year, Company Profile and etc.)
-
Table Biocon Limited HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Limited HER2 ErbB2 Antibodies Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG HER2 ErbB2 Antibodies Product and Service
-
Table Bio-Techne (Novus Biologicals, LLC) (Foundation Year, Company Profile and etc.)
-
Table Bio-Techne (Novus Biologicals, LLC) HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Techne (Novus Biologicals, LLC) HER2 ErbB2 Antibodies Product and Service
-
Table InvivoGen (Foundation Year, Company Profile and etc.)
-
Table InvivoGen HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table InvivoGen HER2 ErbB2 Antibodies Product and Service
-
Table Atlas Antibodies (Foundation Year, Company Profile and etc.)
-
Table Atlas Antibodies HER2 ErbB2 Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Atlas Antibodies HER2 ErbB2 Antibodies Product and Service
-
